Oragen
 |
This article is an orphan, as no other articles link to it. (June 2010) |
Oragen drugs are highly experimental nucleic acid technologies related to Ampligen, developed by HEMISPHERx Biopharma, Inc. It is hoped they will have antiviral effects. They are undergoing pre-clinical (in-vitro) trials.
Mechanism Of Action
It is believed that Oragen regulates the RNase L pathway and may also have effects specifically against the HIV virus.
External links
 |
This immunology article is a stub. You can help Wikipedia by expanding it. |
